ask="19.70"
ask_size="100"
average_daily_volume="185447"
bid="N/A"
bid_size="N/A"
book_value="6.18"
change="-0.65"
change_from_200_day_moving_average="1.62"
change_from_50_day_moving_average="-1.31"
change_from_52_week_high="-5.00"
change_From_52_week_low="6.95"
change_in_percent="-3.26%"
close="19.30"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.18"
ebitda="-77.73M"
eps_estimate_current_year="-3.60"
eps_estimate_next_quarter="-0.93"
eps_estimate_next_year="-3.40"
ex_dividend_date="N/A"
float_shares="18536000"
high="20.60"
high_52_weeks="24.30"
last_trade_date="3/3/2017"
last_trade_price="19.30"
last_trade_size="14085"
last_trade_time="4:00pm"
low="19.10"
low_52_weeks="12.35"
market_capitalization="552.91M"
moving_average_200_day="17.68"
moving_average_50_day="20.61"
name="Revance Therapeutics
Inc."
notes="N/A"
one_year_target_price="39.67"
open="19.90"
pe_ratio="N/A"
peg_ratio="-0.50"
percent_change_from_200_day_moving_average="+9.15%"
percent_change_from_50_day_moving_average="-6.38%"
percent_change_from_52_week_high="-20.58%"
percent_change_from_52_week_low="+56.28%"
previous_close="19.95"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.23"
price_per_sales="1905.09"
revenue="300000.00"
shares_outstanding="28648000"
short_ratio="28.66"
stock_exchange="NGM"
symbol="RVNC"
volume="248116"
weeks_range_52="12.35 - 24.30"
